Phase II neoadjuvant (N-) gemcitabine (G) and pembrolizumab (P) for locally advanced urothelial cancer (laUC): Interim results from the cisplatin (C)-ineligible cohort of GU14-188.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kaimakliotis, HZ; Adra, N; Kelly, WK; Trabulsi, EJ; Lauer, RC; Picus, J; Smith, ZL; Walling, R; Masterson, TA; Calaway, AC; Koch, MO; Sonderman, E; Fu, P; Goolamier, G; Eitman, C; Ponsky, LE; Hoimes, CJ

Published Date

  • May 20, 2020

Published In

Volume / Issue

  • 38 / 15

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X